Erchonia Corporation
Melbourne, Florida, 32904, United States
NCT Number: NCT05626270
Human factors validation testing to assess the intended user's ability to correctly, safely, and effectively set-up, activate and operate the LunulaLaser™ OTC, to administer a treatment to a suitably qualified client, and to understand the information contained in the Erchonia LunulaLaser™ OTC Installation and Proper Use Reference Guide and box labeling.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Melbourne, Florida, 32904, United States
This study is an uncontrolled simulated-use human factors validation testing design to assess the intended user's ability to correctly, safely, and effectively set-up, activate and operate the LunulaLaser™ OTC, to administer a treatment to a suitably qualified client, and to understand the information contained in the Erchonia LunulaLaser™ OTC Installation and Proper Use Reference Guide and box labeling.
The study design is comprehensive in scope and conducted in a manner such that the results will be able to be generalized to the actual intended user and client population under intended conditions of actual use and be adequately sensitive to capture use errors arising from either the user interface design and/or the instructional and informative materials. Study data will be collected in a manner that will facilitate analysis of the root causes of use errors or problems during the testing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The LunulaLaser™ OTC is a nonthermal and non-invasive procedure designed to restore the growth of clear, healthy nails in clients with onychomycosis.
Time frame: Each study session was completed on a single day, for up to 120 minutes
The outcome measure identifies the number of subject users that were defined as a study "pass".
A subject user is determined a study 'pass if the subject satisfactorily completes both the device setup and treatment procedure. If the subject user does not satisfactorily complete either one or both of device setup and/or treatment procedure the subject will be determined a study "fail".
Erchonia Corporation
Industry
Human Factors Validation Testing for Over-the-Counter Use of the Erchonia® LunulaLaser™ OTC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06175013
Bacterial Infections and Mycoses, Dermatomycoses
Quatres Bornes, Mauritius
View Trial DetailsNCT05202366
Bacterial Infections and Mycoses, Dermatomycoses
Fort Worth, Texas, United States
View Trial DetailsNCT00233493
Bacterial Infections and Mycoses, Dermatomycoses
Cleveland, Ohio, United States
View Trial DetailsNCT02022215
Bacterial Infections and Mycoses, Dermatomycoses
Birmingham, Alabama, United States
View Trial Details